Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Price:
1.075 USD
1.42%
Market Closed
Updated:
Apr 29, 2024
Section:
Wall Street
Price Targets
ADAP Price Targets Summary
Adaptimmune Therapeutics PLC
Adaptimmune Therapeutics PLC
Wall Street analysts forecast ADAP stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
ADAP
is 3.57 USD
with a low forecast of 1.01 USD and a high forecast of 9.45 USD.
Lowest
Price Target
1.01
USD
6% Downside
Average
Price Target
3.57
USD
232% Upside
Highest
Price Target
9.45
USD
779% Upside
Adaptimmune Therapeutics PLC Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ADAP's stock price target?
Price Target
3.57
USD
3.57
USD
According to Wall Street analysts, the average 1-year price target for
ADAP
is 3.57 USD
with a low forecast of 1.01 USD and a high forecast of 9.45 USD.
What is Adaptimmune Therapeutics PLC's Revenue forecast?
Projected CAGR
-4%
-4%
For the last 9 years the
compound annual growth rate for
Adaptimmune Therapeutics PLC's revenue is
21%.
The projected
CAGR
for the next 3 years is
-4%.
You don't have any saved screeners yet
